Latest News about INM
Recent news which mentions INM
InMed Pharmaceuticals Announces Publication of Article on CBN as Possible Glaucoma Treatment
December 20, 2021
Tickers
INM
From Benzinga
InMed Pharmaceuticals' Study Marks First Phase 2 Trial to Evaluate Cannabinol for Disease Treatment
December 10, 2021
Tickers
INM
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021
November 29, 2021
From Benzinga
54 Biggest Movers From Yesterday
November 19, 2021
From Benzinga
Welcome to the Party $INM! Competition or Compliment to $SNDL? — Cannabis Daily November 18, 2021
November 18, 2021
From Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
November 18, 2021
From Benzinga
From InvestorPlace
24 Stocks Moving in Thursday's Pre-Market Session
November 18, 2021
From Benzinga
InMed Pharmaceuticals Working to Address Rare Cannabinoid Opportunities
November 17, 2021
Tickers
INM
From Benzinga
InMed Pharmaceuticals Files Patent Application for Treatment of Neurodegenerative Diseases with Rare Cannabinoid
November 11, 2021
Tickers
INM
From Benzinga
InMed Pharmaceuticals Inc. Files PCT Application for Treating Neurodegenerative Disease Using Rare Cannabinoid
November 03, 2021
Tickers
INM
From Benzinga
From Benzinga
From InvestorPlace
55 Biggest Movers From Friday
October 25, 2021
From Benzinga
35 Stocks Moving In Friday's Mid-Day Session
October 22, 2021
From Benzinga
26 Stocks Moving in Friday's Pre-Market Session
October 22, 2021
From Benzinga
23 Stocks Moving in Thursday's Pre-Market Session
October 21, 2021
From Benzinga
From InvestorPlace
46 Biggest Movers From Yesterday
October 19, 2021
From Benzinga
34 Stocks Moving In Monday's Mid-Day Session
October 18, 2021
From Benzinga
From InvestorPlace
21 Stocks Moving in Monday's Pre-Market Session
October 18, 2021
From Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
October 14, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.